| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.800 | strong | 0.972 | 5 | 13 | 1990 | 2020 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.490 | None | 1.000 | 0 | 1 | 2014 | 2019 | ||||||||
|
axin 2 | 0.507 | 0.692 | 0.57 |
|
disease | 0.500 | None | 0.905 | 0 | 3 | 2001 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.976 | 0 | 5 | 2002 | 2020 | ||||||||
|
BCL10 immune signaling adaptor | 0.491 | 0.769 | 0.34 |
|
disease | 0.160 | None | 0.833 | 0 | 1 | 1999 | 2015 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.200 | None | 0.969 | 0 | 1 | 1998 | 2019 | ||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2012 | 2016 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.200 | None | 1.000 | 1 | 3 | 1998 | 2019 | ||||||||
|
BUB1 mitotic checkpoint serine/threonine kinase | 0.528 | 0.731 | 4.9E-09 |
|
disease | 0.700 | None | 1.000 | 0 | 1 | 2000 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.700 | None | 0.983 | 0 | 3 | 1997 | 2020 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.700 | limited | 0.885 | 0 | 1 | 2003 | 2019 | ||||||||
|
cytochrome b | 0.529 | 0.808 |
|
disease | 0.400 | None | 0 | 1 | ||||||||||||
|
cytochrome c oxidase subunit I | 0.441 | 0.885 |
|
disease | 0.500 | None | 1.000 | 0 | 2 | 1994 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.500 | None | 0.975 | 0 | 3 | 1994 | 2020 | |||||||||
|
DCC netrin 1 receptor | 0.471 | 0.808 | 0.99 |
|
disease | 0.700 | None | 0.946 | 0 | 1 | 1990 | 2019 | ||||||||
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
disease | 0.450 | None | 1.000 | 0 | 1 | 2013 | 2019 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.640 | None | 1.000 | 1 | 4 | 1996 | 2017 | ||||||||
|
EP300 antisense RNA 1 | 0.839 | 0.231 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
FA complementation group C | 0.507 | 0.808 | 2.8E-13 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
FA complementation group E | 0.553 | 0.808 | 1.5E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
fibrinogen silencer binding protein | 0.821 | 0.231 | 7.1E-04 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.660 | None | 1.000 | 0 | 8 | 2000 | 2018 | ||||||||
|
folliculin | 0.537 | 0.885 | 0.79 |
|
disease | 0.400 | None | 0 | 4 | |||||||||||
|
long intergenic non-protein coding RNA 1917 | 0.931 | 0.115 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
major facilitator superfamily domain containing 4B | 0.805 | 0.269 | 8.3E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 |